z-logo
Premium
Identification of heterozygotes for glycogenosis 2 (Acid maltase deficiency)
Author(s) -
Loonen M. C. B.,
Schram A. W.,
Koster J. F.,
Niermeijer M. F.,
Busch H. F. M.,
Martin J. J.,
BrouwerKelder B.,
Mekes W.,
Slee R. G.,
Tager J. M.
Publication year - 1981
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/j.1399-0004.1981.tb00668.x
Subject(s) - heterozygote advantage , loss of heterozygosity , biology , compound heterozygosity , biopsy , endocrinology , genotype , medicine , genetics , mutation , gene , allele
In 21 obligate and 9 possible heterozygotes for acid maltase deficiency (AMD) (glycogenosis 2, Pompe's disease), different methods of identifying heterozygotes have been studied. Heterozygosity could not be demonstrated by physical examination, serum CPK assays, morphological examination of a muscle biopsy (including light‐microscopy, histochemistry and electron‐microscopy), or by ultrastructural examination of a skin biopsy. Heterozygotes could be identified to a large, but still limited extent, by measuring the acid α‐glucosidase activity in urine, cultivated fibroblasts, leucocytes, or skeletal muscle. Heterozygotes for the generalized form of AMD could not be distinguished from those for the muscular form. The limitations of heterozygote identification by means of enzyme assays are discussed, and some practical aspects for genetic counselling are mentioned.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here